Literature DB >> 18803399

Structural characterization of binding of Cu(II) to tau protein.

Alice Soragni1, Barbara Zambelli, Marco D Mukrasch, Jacek Biernat, Sadasivam Jeganathan, Christian Griesinger, Stefano Ciurli, Eckhard Mandelkow, Markus Zweckstetter.   

Abstract

Transition metals have been frequently recognized as risk factors in neurodegenerative disorders, and brain lesions associated with Alzheimer's disease are rich in Fe(III), Zn(II), and Cu(II). By using different biophysical techniques (nuclear magnetic resonance, circular dichroism, light scattering, and microcalorimetry), we have structurally characterized the binding of Cu(II) to a 198 amino acid fragment of the protein Tau that can mimic both the aggregation behavior and microtubule binding properties of the full-length protein. We demonstrate that Tau can specifically bind one Cu(II) ion per monomer with a dissociation constant in the micromolar range, an affinity comparable to the binding of Cu(II) to other proteins involved in neurodegenerative diseases. NMR spectroscopy showed that two short stretches of residues, (287)VQSKCGS (293) and (310)YKPVDLSKVTSKCGS (324), are primarily involved in copper binding, in agreement with mutational analysis. According to circular dichroism and NMR spectroscopy, Tau remains largely disordered upon binding to Cu(II), although a limited amount of aggregation is induced.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18803399     DOI: 10.1021/bi8008856

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

Review 1.  Using NMR spectroscopy to investigate the role played by copper in prion diseases.

Authors:  Rawiah A Alsiary; Mawadda Alghrably; Abdelhamid Saoudi; Suliman Al-Ghamdi; Lukasz Jaremko; Mariusz Jaremko; Abdul-Hamid Emwas
Journal:  Neurol Sci       Date:  2020-04-24       Impact factor: 3.307

Review 2.  Physicochemical properties of cells and their effects on intrinsically disordered proteins (IDPs).

Authors:  Francois-Xavier Theillet; Andres Binolfi; Tamara Frembgen-Kesner; Karan Hingorani; Mohona Sarkar; Ciara Kyne; Conggang Li; Peter B Crowley; Lila Gierasch; Gary J Pielak; Adrian H Elcock; Anne Gershenson; Philipp Selenko
Journal:  Chem Rev       Date:  2014-06-05       Impact factor: 60.622

3.  Zinc and Copper Differentially Modulate Amyloid Precursor Protein Processing by γ-Secretase and Amyloid-β Peptide Production.

Authors:  Hermeto Gerber; Fang Wu; Mitko Dimitrov; Guillermo M Garcia Osuna; Patrick C Fraering
Journal:  J Biol Chem       Date:  2017-01-17       Impact factor: 5.157

4.  Intrinsic α helix propensities compact hydrodynamic radii in intrinsically disordered proteins.

Authors:  Lance R English; Erin C Tilton; Benjamin J Ricard; Steven T Whitten
Journal:  Proteins       Date:  2017-01-05

Review 5.  Biometals and their therapeutic implications in Alzheimer's disease.

Authors:  Scott Ayton; Peng Lei; Ashley I Bush
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

Review 6.  Copper in the brain and Alzheimer's disease.

Authors:  Ya Hui Hung; Ashley I Bush; Robert Alan Cherny
Journal:  J Biol Inorg Chem       Date:  2009-10-28       Impact factor: 3.358

7.  Low micromolar zinc accelerates the fibrillization of human tau via bridging of Cys-291 and Cys-322.

Authors:  Zhong-Ying Mo; Ying-Zhu Zhu; Hai-Li Zhu; Jun-Bao Fan; Jie Chen; Yi Liang
Journal:  J Biol Chem       Date:  2009-10-13       Impact factor: 5.157

8.  Alanine and proline content modulate global sensitivity to discrete perturbations in disordered proteins.

Authors:  Romel B Perez; Alexander Tischer; Matthew Auton; Steven T Whitten
Journal:  Proteins       Date:  2014-10-10

9.  Disturbed copper bioavailability in Alzheimer's disease.

Authors:  Daniela Kaden; Ashley I Bush; Ruth Danzeisen; Thomas A Bayer; Gerd Multhaup
Journal:  Int J Alzheimers Dis       Date:  2011-11-15

10.  Links between copper and cholesterol in Alzheimer's disease.

Authors:  Ya Hui Hung; Ashley I Bush; Sharon La Fontaine
Journal:  Front Physiol       Date:  2013-05-16       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.